A Rac1/PAK1 cascade controls Β-catenin activation in colon cancer cells

Oncogene

Volumn 31, Issue 8, 2012, Pages 1001-1012

  Zhu, G ^a   Wang, Y ^a   Huang, B ^a   Liang, J ^a   Ding, Y ^a   Xu, A ^b   Wu, W ^a  

^a TSINGHUA UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

b catenin; colon cancer; PAK1; phosphorylation; Rac1

Indexed keywords

BETA CATENIN; P21 ACTIVATED KINASE 1; RAC1 PROTEIN; SERINE;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; BETA CATENIN; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; ENZYME ACTIVATION; GENE EXPRESSION; HCT116 CELLS; HEK293 CELLS; HUMANS; MICE; P21-ACTIVATED KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STABILITY; RAC1 GTP-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; WNT SIGNALING PATHWAY;

EID: 84857364721     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.294     Document Type: Article

References (54)

1. Anderson CB, Neufeld KL, White RL. (2002). Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci USA 99: 8683-8688. (Pubitemid 34693620)
2. Arias-Romero LE, Chernoff J. (2008). A tale of two Paks. Biol Cell 100: 97-108. (Pubitemid 351266767)
3. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK et al. (2004). p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 279: 1422-1428. (Pubitemid 38082670)
4. Bienz M, Clevers H. (2000). Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
5. Bikkavilli RK, Feigin ME, Malbon CC. (2008). G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells. J Cell Sci 121: 234-245. (Pubitemid 351232664)
6. Billin AN, Thirlwell H, Ayer DE. (2000). Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 20: 6882-6890.
7. Bokoch GM. (2003). Biology of the p21-activated kinases. Annu Rev Biochem 72: 743-781. (Pubitemid 36930459)
8. Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO et al. (2004). Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 10: 3448-3456. (Pubitemid 38685452)
9. Clevers H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
10. Deacon SW, Beeser A, Fukui JA, Rennefahrt UE, Myers C, Chernoff J et al. (2008). An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 15: 322-331. (Pubitemid 351508427)
11. Dummler B, Ohshiro K, Kumar R, Field J. (2009). Pak protein kinases and their role in cancer. Cancer Metastasis Rev 28: 51-63.
12. Esufali S, Bapat B. (2004). Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Oncogene 23: 8260-8271. (Pubitemid 39531837)
13. Fang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H et al. (2007). Phosphorylation of beta-catenin by AKT promotes betacatenin transcriptional activity. J Biol Chem 282: 11221-11229. (Pubitemid 47100795)
14. Galisteo ML, Chernoff J, Su YC, Skolnik EY, Schlessinger J. (1996). The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1. J Biol Chem 271: 20997-21000. (Pubitemid 26292943)
15. Giles RH, van Es JH, Clevers H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24. (Pubitemid 36627817)
16. Habas R, Dawid IB, He X. (2003). Coactivation of Rac and Rho by Wnt/frizzled signaling is required for vertebrate gastrulation. Genes Dev 17: 295-309. (Pubitemid 36105900)
17. He H, Shulkes A, Baldwin GS. (2008). PAK1 interacts with betacatenin and is required for the regulation of the beta-catenin signalling pathway by gastrins. Biochim Biophys Acta 1783: 1943-1954.
18. Hendriksen J, Jansen M, Brown CM, van der Velde H, van Ham M, Galjart N et al. (2008). Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. J Cell Sci 121: 1793-1802. (Pubitemid 351943372)
19. Hino S, Tanji C, Nakayama KI, Kikuchi A. (2005). Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Mol Cell Biol 25: 9063-9072. (Pubitemid 41429094)
20. Huynh N, Liu KH, Baldwin GS, He H. (2010). P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK-and AKT-dependent pathways. Biochim Biophys Acta 1803: 1106-1113.
21. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF. (1997). Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci USA 94: 10330-10334. (Pubitemid 27407041)
22. Jacobs T, Causeret F, Nishimura YV, Terao M, Norman A, Hoshino M et al. (2007). Localized activation of p21-activated kinase controls neuronal polarity and morphology. J Neurosci 27: 8604-8615. (Pubitemid 47254258)
23. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. (1997). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APCR/F colon carcinoma. Science 275: 1784-1787. (Pubitemid 27136714)
24. Kumar R, Gururaj AE, Barnes CJ. (2006). p21-activated kinases in cancer. Nat Rev Cancer 6: 459-471.
25. Lee SH, Kunz J, Lin SH, Yu-Lee LY. (2007). 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res 67: 11045-11053. (Pubitemid 350145935)
26. Logan CY, Nusse R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810. (Pubitemid 39488658)
27. Lu W, Katz S, Gupta R, Mayer BJ. (1997). Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol 7: 85-94. (Pubitemid 27155617)
28. Lu Z, Hunter T. (2004). Wnt-independent beta-catenin transactivation in tumor development. Cell Cycle 3: 571-573. (Pubitemid 40278191)
29. MacDonald BT, Tamai K, He X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
30. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. (1994). A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367: 40-46. (Pubitemid 24038530)
31. Molli PR, Li DQ, Murray BW, Rayala SK, Kumar R. (2009). PAK signaling in oncogenesis. Oncogene 28: 2545-2555.
32. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701. (Pubitemid 39150127)
33. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790. (Pubitemid 27136715)
34. Mosimann C, Hausmann G, Basler K. (2009). Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10: 276-286.
35. Nheu T, He H, Hirokawa Y, Walker F, Wood J, Maruta H. (2004). PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition. Cell Cycle 3: 71-74. (Pubitemid 40268591)
36. Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, Rai K et al. (2009). A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137: 623-634.
37. Polakis P. (2000). Wnt signaling and cancer. Genes Dev 14: 1837-1851. (Pubitemid 30639518)
38. Polakis P. (2002). Casein kinase 1: a Wnt'er of disconnect. Curr Biol 12: R499-R501. (Pubitemid 34801162)
39. Rennefahrt UE, Deacon SW, Parker SA, Devarajan K, Beeser A, Chernoff J et al. (2007). Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J Biol Chem 282: 15667-15678. (Pubitemid 47093302)
40. Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K. (2004). Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Oncogene 23: 8447-8454. (Pubitemid 39540795)
41. Segditsas S, Sieber OM, Rowan A, Setien F, Neale K, Phillips RK et al. (2008). Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Exp Mol Pathol 85: 201-206.
42. Sun J, Khalid S, Rozakis-Adcock M, Fantus IG, Jin T. (2009). P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine. Oncogene 28: 3132-3144.
43. Tang Y, Chen Z, Ambrose D, Liu J, Gibbs JB, Chernoff J et al. (1997). Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol Cell Biol 17: 4454-4464. (Pubitemid 27318122)
44. Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. (2006). Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem 281: 9971-9976. (Pubitemid 43864529)
45. Valentini AM, Pirrelli M, Renna L, Armentano R, Caruso ML. (2003). P53 and beta-catenin in colorectal cancer progression. Curr Pharm Des 9: 1932-1936. (Pubitemid 37010097)
46. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al. (2003). Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615. (Pubitemid 36939953)
47. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250. (Pubitemid 35292444)
48. Wang RA,Mazumdar A, Vadlamudi RK, Kumar R. (2002). P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J 21: 5437-5447. (Pubitemid 35231023)
49. Wang Y, Fu Y, Gao L, Zhu G, Liang J, Gao C et al. (2010a). Xenopus skip modulates Wnt/beta-catenin signaling and functions in neural crest induction. J Biol Chem 285: 10890-10901.
50. Wang Z, Pedersen E, Basse A, Lefever T, Peyrollier K, Kapoor S et al. (2010b). Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene 29: 3362-3373.
51. Wells CM, Jones GE. (2010). The emerging importance of group II PAKs. Biochem J 425: 465-473.
52. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. (2008). Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133: 340-353. (Pubitemid 351508298)
53. Xiao GH, Beeser A, Chernoff J, Testa JR. (2002). p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem 277: 883-886. (Pubitemid 34968830)
54. Xing Y, Clements WK, Le Trong I, Hinds TR, Stenkamp R, Kimelman D et al. (2004). Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function. Mol Cell 15: 523-533. (Pubitemid 39141780)